The Journal of Pediatrics
Volume 149, Issue 4 , Pages 448-451 , October 2006

New rotavirus vaccines: Renewed optimism

  • Miguel O’Ryan, MD

      Affiliations

    • Dr O’Ryan was the principal investigator for the Multicenter Human Rotavirus Vaccine Trial sponsored by GlaxoSmithKline Biologicals. Dr O’Ryan has received consulting and lecture fees from GlaxoSmithKline Biologicals.
    • Corresponding Author InformationReprint requests: Dr Miguel O’Ryan, University of Chile, Department of Microbiology, Unidad Oriente, Facultad de Medicina, Santiago, Chile.
    • ,
  • David O. Matson, MD, PhD

      Affiliations

    • Dr Matson was the principal investigator in the US for the Multicenter Bovine-Human Pentavalent Reassortant Vaccine Trial sponsored by Merck and Co. Dr Matson has received grant support and consulting fees from Merck and Co.

Received 3 March 2006 ,Revised 9 May 2006 ,Accepted 11 July 2006.

References 

  1. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis. 2006;12:304–306
  2. Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med. 1996;335:1022–1028
  3. O’Ryan M, Pérez-Schael I, Mamani N, Peña A, Salinas B, González G, et al. Rotavirus-associated medical visits and hospitalizations in South America: a prospective study at three large sentinel hospitals. Ped Infect Dis J. 2001;20:685–693
  4. Malek MA, Curns AT, Holman RC, Fischer TK, Bresee JS, Glass RI, et al. Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics. 2006;117:1887–1892
  5. Matson DO, O’Ryan ML, Jiang X, Mitchell DK. Rotavirus, enteric adenoviruses, caliciviruses, astroviruses, and other viruses causing gastroenteritis. In:  Spector S,  Hodinka RL,  Young SA editor. Clinical Virology Manual. 3rd ed.. Washington DC: ASM Press; 2000;p. 270–294
  6. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol. 2005;5:29–56
  7. Gentsch JR, Woods PA, Ramachandran M, Das BK, Leite JP, Alfieri A, et al. Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J Infect Dis. 1996;74(suppl 1):S30–S36
  8. Unicomb L, Podder G, Gentsch J, Woods P, Hasan Z, Faruque ASG, et al. Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995. J Clin Microb. 1999;37:1885–1891
  9. Banyai K, Gentsch JR, Schipp R, Jakab F, Meleg E, Mihaly I, et al. Dominating prevalence of P[8],G1 and P[8],G9 rotavirus strains among children admitted to hospital between 2000 and 2003 in Budapest, Hungary. J Med Virol. 2005;76:414–423
  10. Rahman M, Matthijnssens J, Goegebuer T, De Leener K, Vanderwegen L, van der Donck I, et al. Predominance of rotavirus G9 genotype in children hospitalized for rotavirus gastroenteritis in Belgium during 1999-2003. J Clin Virol. 2005;33:1–6
  11. Ramachandran M, Das B, Vij A, Kumar R, Bhambal S, Kesari N, et al. Unusual diversity of human rotavirus G and P genotypes in India. J Clin Microb. 1996;34:436–439
  12. Santos N, Lima R, Pereira C, Gouvea V. Detection of rotavirus types G8 and G10 among Brazilian children with diarrhea. J Clin Microbiol. 1998;36:2727–2729
  13. O’Ryan ML, Matson DO, Estes MK, Pickering LK. Molecular epidemiology of rotavirus in children attending day care centers in Houston. J Infect Dis. 1990;162:810–816
  14. O’Ryan ML, Matson DO, Pickering LK, Estes MK. Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections. J Infect Dis. 1994;169:504–511
  15. O’Ryan ML, Matson DO, Pickering LK, Estes MK. Acquisition of serum isotype-specific and G type-specific antirotavirus antibodies among children in day care centers. Pediatr Infect Dis J. 1994;13:890–895
  16. Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. JAMA. 1995;273:1191–1196
  17. Santosham M, Moulton LH, Reid R, Croll J, Weatherholt R, Ward R, et al. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in native American populations. J Pediatr. 1997;131:632–638
  18. Perez-Schael I, Guntinas MJ, Perez M, Pagone V, Rojas AM, Gonzalez R, et al. Efficacy of the rhesus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med. 1997;337:1181–1187
  19. Joensuu J, Koskenniemie E, Pang XL, Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet. 1997;350:1205–1209
  20. Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET, et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines: report of the national multicenter trial. Pediatrics. 1996;97:7–13
  21. Peters G, Myers M. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics. 2002;110:67–72
  22. O′Ryan M, Lucero Y, Peña A, Valenzuela MT. Two-year review of intestinal intussusception in six large public hospitals of Santiago, Chile. Ped Infect Dis J. 2003;22:717–721
  23. Nakagomi T, Takahashi Y, Arisawa K, Nakagomi O. A high incidence of intussusception in Japan as studied in a sentinel hospital over a 25-year period (1978-2002). Epidemiol Infect. 2006;134:57–61
  24. De Vos B, Vesikari T, Linhares AC, Salinas B, Perez-Schael I, Ruiz-Palacios GM, et al. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr Infect Dis J. 2004;23(10 suppl):S179–S182
  25. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22
  26. Estes MK, Kang G, Zeng CO, Crawford SE, Ciarlet M. Pathogenesis of rotavirus gastroenteritis. Novartis Found Symp. 2001;238:82–96
  27. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirusvaccine. N Engl J Med. 2006;354:23–33

PII: S0022-3476(06)00682-2

doi: 10.1016/j.jpeds.2006.07.018

The Journal of Pediatrics
Volume 149, Issue 4 , Pages 448-451 , October 2006

Article Tools